Blepharitis Market to Observe Stupendous Growth During the Forecast Period – DelveInsight | Key Companies – AxeroVision, Premark Pharma, Sun Pharma, Tarsus Pharmaceuticals, Nicox Ophthalmics

 Breaking News
  • No posts were found

Blepharitis Market to Observe Stupendous Growth During the Forecast Period – DelveInsight | Key Companies – AxeroVision, Premark Pharma, Sun Pharma, Tarsus Pharmaceuticals, Nicox Ophthalmics

Blepharitis Market to Observe Stupendous Growth During the Forecast Period - DelveInsight | Key Companies - AxeroVision, Premark Pharma, Sun Pharma, Tarsus Pharmaceuticals, Nicox Ophthalmics
Delveinsight Business Research LLP
As per DelveInsight, the Blepharitis Market dynamics are expected to transform in the coming years owing to the rise in the number of prevalent/ incident cases, the launch of emerging therapies, ongoing Research and Development (R&D) activities, and the active participation of the global pharma and biotech giants in the therapeutic segment. Several key companies are active in the therapeutic domain, and the therapies under development are focused on novel approaches to treat the disease.

DelveInsight’s “Blepharitis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Blepharitis Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Blepharitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Blepharitis: An Overview

According to the American Optometric Association, “Blepharitis is an inflammation of the eyelids in which they become red, irritated, itchy, and dandruff-like scales form on the eyelashes”. It is a chronic external eye disorder resulting in red, burning, and irritated eyes, which do not cause serious damage to the eyes but can be very uncomfortable. It can be caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea.

Blepharitis is a complex disease and has multiple causes. It cannot be cured; however, it can be controlled. Generally, the disease starts slowly, affecting both eyes, and usually becomes chronic with periods of remission and relapse. Patients over the age of 18 are more likely to be affected, but the disease is also found in children. If not recognized and appropriately managed, it can lead to worsening of signs and symptoms: disrupted preocular tear film, discomfort and changes in visual function, and negative effect on patient quality of life.

Blepharitis Market Key Facts

  • According to systematic literature reviews and surveys of US ophthalmologists and optometrists, 37–47% of patients have been found to have signs of blepharitis.

  • According to DelveInsight’s analysis, Blepharitis is slightly more common in females than in males

  • Cursiefen et al. conducted a study titled “Unmet Needs in Ophthalmology: A European Vision Institute-Consensus Roadmap 2019–2025”, which suggests that blepharitis contributes to 80% of all dry eye diseases.

Blepharitis Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Blepharitis market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Blepharitis market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Blepharitis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Blepharitis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Blepharitis market or expected to get launched during the study period. The analysis covers the Blepharitis market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Blepharitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Blepharitis Therapeutics Analysis

The Blepharitis therapeutics market is expected to increase in the coming years owing to the rising prevalent population, technological advancements in the domain, and the launch of upcoming therapies.

Some of the key companies in the Blepharitis market include:

  • AxeroVision

  • Premark Pharma

  • Sun Pharma

  • Tarsus Pharmaceuticals

  • Nicox Ophthalmics

And others.

Blepharitis Therapies covered in the report include:

  • AXR-270

  • PMP2207

  • TP-03

  • Fluticasone Propionate

  • ISV-305 (DexaSite)

And many others

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Blepharitis Competitive Intelligence Analysis

4. Blepharitis Market Overview at a Glance

5. Blepharitis Disease Background and Overview

6. Blepharitis Patient Journey

7. Blepharitis Epidemiology and Patient Population

8. Blepharitis Treatment Algorithm, Current Treatment, and Medical Practices

9. Blepharitis Unmet Needs

10. Key Endpoints of Blepharitis Treatment

11. Blepharitis Marketed Products

12. Blepharitis Emerging Therapies

13. Blepharitis Seven Major Market Analysis

14. Attribute Analysis

15. Blepharitis Market Outlook (7 major markets)

16. Blepharitis Access and Reimbursement Overview

17. KOL Views on the Blepharitis Market.

18. Blepharitis Market Drivers

19. Blepharitis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Glabellar Frown Lines Market
“Glabellar Frown Lines Market” research report provides a detailed overview of the historical and forecasted epidemiology and the Glabellar Frown Lines Market size, share, and trends in the 7MM. Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics Market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States